Novartis Korea to promote local venture projects

Published: 2008-03-20 06:57:00

Updated: 2008-03-20 06:57:00

Novartis Korea plans to make its investment on Korea's three venture start-ups this year for joint research and development (R&D) of new drugs and medical technology.

Novartis Korea, the Korea Trade-Investment Promotion Agency and the Korea Health Industry Development Institute signed a memora...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK